Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways
BMB Reports · 31.08.2025 · 58 (8) · 357-363
DOI: 10.5483/bmbrep.2024-0115 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMB Reports, online erschienen am 13.06.2025. Verfasst von Chandani Shrestha und 7 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Shrestha, C., Yoo, E. H., Deshar, B., Hwang, M., Kang, S., Bin, B., Lee, J. H., & Kim, J. (2025). Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways. BMB Reports, 58(8), 357-363. https://doi.org/10.5483/bmbrep.2024-0115
Vancouver
Shrestha C, Yoo EH, Deshar B, Hwang M, Kang S, Bin B, et al. Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways. BMB Reports. 2025;58(8):357-363. doi:10.5483/bmbrep.2024-0115
BibTeX
@article{Shrestha2025,
author = {Shrestha, Chandani and Yoo, Eun Hee and Deshar, Barsha and Hwang, Min and Kang, Shinwon and Bin, Bum-Ho and Lee, Ji Hyun and Kim, Jiyoon},
title = {Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways},
journal = {BMB Reports},
year = {2025},
volume = {58},
number = {8},
pages = {357--363},
doi = {10.5483/bmbrep.2024-0115}
}
EUVIMED